Managing Facial Hyperpigmentation
This JAMA Network Insight describes dermatologists ’ role in managing hyperpigmentation, from counseling on photoprotection to prescribing treatment regimens, for this psychosocially distressing entity. (Source: JAMA Dermatology)
Source: JAMA Dermatology - June 7, 2023 Category: Dermatology Source Type: research
Erythrokeratodermia
This case report describes well-defined, polycyclic, and geographic hyperkeratotic plaques that involved the axillae, chest, flanks, inguinal folds, and buttocks. (Source: JAMA Dermatology)
Source: JAMA Dermatology - June 7, 2023 Category: Dermatology Source Type: research
Melanoma In Situ —Getting the Diagnosis and Prognosis Right
In this issue of JAMA Dermatology, Patel and colleagues examine mortality after a diagnosis of melanoma in situ. Melanoma in situ is the earliest stage of melanoma (stage 0) and is localized to the outermost layer of skin (epidermis). It is regarded as a potential precursor lesion to invasive melanoma (stages I to IV), in which melanoma invades the deeper layers of the skin and, in doing so, acquires the potential ability to spread to distant sites, which may ultimately lead to death from melanoma. Nevertheless, melanoma in situ is not an obligate precursor of invasive melanoma, and it is increasingly acknowledged that som...
Source: JAMA Dermatology - June 7, 2023 Category: Dermatology Source Type: research
Fever, Pancytopenia, and Tender Erythematous Plaques in a Patient With Multiple Myeloma
A man in his late 60s who had received the first cycle of a chemotherapeutic regimen of ixazomib, lenalidomide, and dexamethasone for multiple myeloma presented to the dermatologic clinic with a 10-day history of fever and tender lesions on the neck and trunk. What is your diagnosis? (Source: JAMA Dermatology)
Source: JAMA Dermatology - June 7, 2023 Category: Dermatology Source Type: research
Venous Thromboembolism and Bullous Pemphigoid
This cohort study using US claims data examines the incidence of venous thromboembolism in patients with bullous pemphigoid compared with similar controls. (Source: JAMA Dermatology)
Source: JAMA Dermatology - June 7, 2023 Category: Dermatology Source Type: research
